DERMAHAN THE WHITENING MOISTURIZING MASK

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DERMAHAN THE WHITENING MOISTURIZING MASK
Generic name: NIACINAMIDE, ADENOSINE
Manufacturer: LAON COMMERCE co ltd
Product type: HUMAN OTC DRUG
SPL set ID: cf131624-b223-55c0-e053-2995a90a31f3
SPL ID: cf131624-b222-55c0-e053-2995a90a31f3
Version: 1
Effective date: 2021-10-24
Source export date: 2026-10-30
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/3b4c9bc1c064560160661a043b9878894ba805e5e90f4733fb76824b6ba7ac42/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:24:40

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		DERMAHAN THE WHITENING MOISTURIZING MASK	openfda.brand_name
generic name		NIACINAMIDE, ADENOSINE	openfda.generic_name
manufacturer name		LAON COMMERCE co ltd	openfda.manufacturer_name
ndc	package	82083-0003-1	openfda.package_ndc
ndc	product	82083-0003	openfda.product_ndc
ndc11	package	82083000301	derived:openfda.package_ndc
spl id		cf131624-b222-55c0-e053-2995a90a31f3	id
spl set id		cf131624-b223-55c0-e053-2995a90a31f3	set_id
unii		25X51I8RD4	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

■ if following abnormal symptoms persist, discontinue use Irritation around the eyes, ears, mucous membranes, including the mouth, under the skin irritation and rashes ■ Stop immediately and consult a doctor if you experience 1) Hypersensitivity symptoms such as erythema, itching and dermatitis. 2) Skin Irritation 3) Following Instructions when using medication (1) For external use only (Do not use internally) (2) Avoid getting into the eyes (if contact occurs, wash well with clean water)

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.